Clostridium difficileinfection (CDI) is a leading cause of hospital-associated gastrointestinal
illness and places a high burden on our health-care system. Patients with CDI typically have …

Background Clostridium difficile infection (CDI) can lead to complications, recurrence, and
death. Numerous studies have assessed risk factors for these unfavourable outcomes, but …

Background Faecal microbiota transplantation (FMT) from healthy donors is considered an
effective treatment against recurrent Clostridium difficile infection. Aim To study the effect of …

Background Clostridium difficile infection (CDI) continues to be a frequent and potentially
severe infection. There is currently no validated clinical tool for use at the time of CDI …

We aimed to describe the clinical presentation, treatment, outcome and report on factors
associated with mortality over a 90-day period in Clostridioides difficile infection (CDI) …

Objective. To compare 8 severity score indices for Clostridium difficile infection (CDI).
Design. Prospective observational study. Methods. This study was conducted from July …

Aliment Pharmacol Ther 31, 754–759 Summary Background Proton pump inhibitors (PPIs)
and H2 receptor antagonists (H2RAs) may play an important role on the onset of Clostridium …

BACKGROUND & AIMS: Several risk factors have been identified for the development of
recurrent Clostridium difficile infection (CDI) that alter host immunity and disrupt colonic flora …

Context Identifying patients at risk for adverse outcomes of Clostridium difficile infection
(CDI), including recurrence and death, will become increasingly important as novel …

Background The increasing incidence of Clostridium difficile (C. difficile) infection (CDI)
among patients with inflammatory bowel disease is well recognised. However, most studies …